Related Experiment Video
Updated: Jan 17, 2026
Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Breaking the Paradigm: Successful Treatment of Rare CD4/CD8 Dual-Positive, Advanced Mycosis Fungoides Using CHOP
Cecilia Arias Sepúlveda1, Diego E Gómez López2, Kenia Hernandez Rivera1
1Internal Medicine Residency, Autonomous University of Chihuahua/Institute for Social Security and Services for State Workers (ISSSTE) President Lazaro Cárdenas, Chihuahua, MEX.
None:
Mycosis fungoides (MF) is one of the most important representatives of cutaneous T-cell lymphomas. This disease is rare, and the diagnosis always requires a clinical-pathological correlation. The prognosis depends on its stage and is usually favorable when found in early stages. CD4/CD8 duality is an uncommon immune phenotype. We are presenting a successful treatment of a case of dual-positive MF in the third stage. The simultaneous expression of CD4 and CD8 in skin lesions has been suggested to potentially indicate an improved clinical outcome in patients with MF. Patient was treated with the CHOP regimen and a combination of symptomatic therapies, which resulted in a favorable therapeutic response.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers